2022

Li, Y., Rönn, M., Tuite, A., Chesson, H., Gift, T., Trikalinos, T., Testa, C., Bellerose, M., Hsu, K., Berruti, A., Malyuta, Y., Menzies, N., & Salomon, J. (2022). Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the United States: A modelling study of overall burden and disparities by age, race/ethnicity, and other factors. Lancet Regional Health Americas, 16. https://doi.org/10.1016/j.lana.2022.100364

Zhong, H., Brandeau, M., Yazdi, G., Wang, J., Nolen, S., Hagan, L., Thompson, W., Assoumou, S., Linas, B., & Salomon, J. (2022). Metamodeling for policy simulations with multivariate outcomes. Medical Decision Making, 42(7). https://doi.org/10.1177/0272989X221105079

Lee, K., You, S., Li, Y., Chesson, H., Gift, T., Berruti, A., Hsu, K., Yaesoubi, R., Salomon, J., & Rönn, M. (2022). Estimation of the lifetime quality-adjusted life years (QALYs) lost due to syphilis acquired in the United States in 2018. Clinical Infectious Diseases, 76(3), e810–e819. https://doi.org/10.1093/cid/ciac427

Kim, S., Cohen, T., Horsburgh, C., Miller, J., Hill, A., Marks, S., Li, R., Kammerer, J., Salomon, J., & Menzies, N. (2022). Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States. Clinical Infectious Diseases, 74(9), 1594–1603. https://doi.org/10.1093/cid/ciab668

Yaesoubi, R., Cohen, T., Hsu, K., Gift, T., St Cyr , S., Salomon, J., & Grad, Y. (2022). Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics. PLoS Computational Biology, 18(2). https://doi.org/10.1371/journal.pcbi.1009842

Toy, M., Hutton, D., Harris, A., Nelson, N., Salomon, J., & So, S. (2022). Cost-effectiveness of one-time universal screening for chronic hepatitis B infection in adults in the United States. Clinical Infectious Diseases, 74(215), 210–217. https://doi.org/10.1093/cid/ciab405

Menzies, N., Shrestha, S., Parriott, A., Marks, S., Hill, A., Dowdy, D., Shete, P., Cohen, T., & Salomon, J. (2022). The health and economic benefits of tests that predict future progression to tuberculosis disease. Epidemiology, 33(1), 75-83. https://doi.org/10.1097/EDE.0000000000001418

Gonsalves, G., Salomon, J., Thornhill, T., & Paltiel, A. (2022). Adventures in COVID-19 policy modeling: Education edition. Current HIV/AIDS Reports, 19(1), 94-100. https://doi.org/10.1007/s11904-021-00592-9

Hutton , D., Toy, M., Salomon, J., Conners, E., Nelson, N., Harris, A., & So, S. (2022). Cost-effectiveness of hepatitis B testing and vaccination of adults seeking care for sexually transmitted infections. Sexually Transmitted Diseases, 49(7), 517-525. https://doi.org/10.1097/OLQ.0000000000001632

Chin, E., Leidner, D., Zhang, Y., Long, E., Prince, L., Schrag, S., Verani, J., Wiegand, R., Alarid-Escudero, F., Goldhaber-Fiebert, J., Studdert, D., Andrews, J., & Salomon, J. (2022). Effectiveness of COVID-19 vaccines among incarcerated people in California state prisons: Retrospective cohort study. Clinical Infectious Diseases, 75(1), e838-e845. https://doi.org/10.1093/cid/ciab1032

Bilinski, A., Ciaranello, A., Fitzpatrick, M., Giardina, J., Shah, M., Salomon, J., & Kendall, E. (2022). Estimated transmission outcomes and costs of SARS-CoV-2 diagnostic testing, screening, and surveillance strategies among a simulated population of primary school students. JAMA Pediatrics, 176(7), 679-689. https://doi.org/10.1001/jamapediatrics.2022.1326

Salomon, J., & Bilinski, A. (2022). Evaluating the performance of Centers for Disease Control and Prevention COVID-19 community levels as leading indicators of COVID-19 mortality. Annals of Internal Medicine, 175(9), 1240-1249. https://doi.org/10.7326/M22-0803

Giardina, J., Bilinski, A., Fitzpatrick, M., Kendall, E., Linas , B., Salomon, J., & Ciaranello, A. (2022). Model-estimated association between simulated US elementary school-related SARS-CoV-2 transmission, mitigation interventions, and vaccine coverage across local incidence levels. JAMA Network Open, 5(2), e2147827. https://doi.org/10.1001/jamanetworkopen.2021.47827

Haber, N., Clarke-Deelder, E., Feller, A., Smith, E., Salomon, J., MacCormack- Gelles, B., Stone, E., Bolster-Foucault, C., Daw, J., Hatfield, L., Fry, C., Boyer , C., Ben-Michael, E., Joyce, C., Linas, B., Schmid, I., Au, E., Wieten, S., Jarrett, B., Axfors, C., Nguyen, V., Griffin, B., Bilinski, A., & Stuart, E. (2022). Problems with evidence assessment in COVID-19 health policy impact evaluation: A systematic review of study design and evidence strength. BMJ Open, 12(1), e053820. https://doi.org/10.1136/bmjopen-2021-053820

Asabor , E., Warren , J., & Cohen, T. (2022). Racial/Ethnic segregation and access to COVID-19 testing: Spatial distribution of COVID-19 testing sites in the four largest highly segregated cities in the United States. American Journal of Public Health, 112(3), 518-526. https://doi.org/10.2105/AJPH.2021.306558